Hologic, Inc. - Common Stock (NQ:HOLX)

76.01 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Friday's pre-market session: top gainers and losers in the S&P500 index ↗

January 31, 2025

Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.

Via Chartmill

5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself ↗

January 23, 2025

S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI investments.

Via Benzinga

How Is The Market Feeling About Hologic? ↗

January 23, 2025

Via Benzinga

New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide

January 21, 2025

From Hologic, Inc.

Via Business Wire

Peering Into Hologic's Recent Short Interest ↗

December 18, 2024

Via Benzinga

Expert Ratings For Hologic ↗

December 10, 2024

Via Benzinga

Peering Into Hologic's Recent Short Interest ↗

November 27, 2024

Via Benzinga

FDA Warns Hologic Over BioZorb Manufacturing Violations ↗

January 17, 2025

FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted

Via Benzinga

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025

January 12, 2025

From Hologic, Inc.

Via Business Wire

Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

From Hologic, Inc.

Via Business Wire

Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025

January 06, 2025

From Hologic, Inc.

Via Business Wire

Looking Into Hologic's Recent Short Interest ↗

November 06, 2024

Via Benzinga

Assessing Hologic: Insights From 10 Financial Analysts ↗

October 04, 2024

Via Benzinga

Hologic Completes Acquisition of Gynesonics, Inc.

January 06, 2025

From Hologic, Inc.

Via Business Wire

Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC

December 18, 2024

From Hologic, Inc.

Via Business Wire

Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines

December 10, 2024

From Hologic, Inc.

Via Business Wire

$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today ↗

September 30, 2024

Via Benzinga

This James Hardie Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

December 10, 2024

Via Benzinga

Martin Madaus Elected to Hologic Board of Directors

December 09, 2024

From Hologic, Inc.

Via Business Wire

New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence

December 09, 2024

From Hologic, Inc.

Via Business Wire

Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations

December 02, 2024

From Hologic, Inc.

Via Business Wire

Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024

November 25, 2024

From Hologic, Inc.

Via Business Wire

Hologic to Webcast Presentations at Upcoming Investor Conferences

November 14, 2024

From Hologic, Inc.

Via Business Wire

Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024

November 04, 2024

From Hologic, Inc.

Via Business Wire

Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday? ↗

November 04, 2024

The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday.

Via Benzinga

Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints ↗

October 25, 2024

FDA and Hologic advise health providers to return all unused BioZorb Markers due to adverse events, including pain and infection.

Via Benzinga

Topics Product Recall

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments ↗

October 14, 2024

Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup. The acquisition aims to boost Hologic's women's health offerings and expand minimally...

Via Benzinga

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health

October 14, 2024

From Hologic, Inc.

Via Business Wire

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024

October 04, 2024

From Hologic, Inc.

Via Business Wire

Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month

September 30, 2024

From Hologic, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.